Better Therapeutics, Inc. (BTTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -38.26 Million USD | -25.2% |
| 2021 | -30.56 Million USD | -389.12% |
| 2020 | -6.24 Million USD | -9.59% |
| 2019 | -5.7 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | -5.34 Million USD | 14.24% |
| 2023 Q1 | -8.92 Million USD | -7.25% |
| 2023 Q2 | -6.22 Million USD | 30.22% |
| 2022 Q3 | -10.3 Million USD | -15.13% |
| 2022 Q2 | -8.94 Million USD | -3.06% |
| 2022 Q1 | -8.68 Million USD | 28.27% |
| 2022 FY | - USD | -25.2% |
| 2022 Q4 | -8.32 Million USD | 19.22% |
| 2021 FY | - USD | -389.12% |
| 2021 Q4 | -12.1 Million USD | -4935.07% |
| 2021 Q3 | -240.39 Thousand USD | 95.96% |
| 2021 Q2 | -5.94 Million USD | -100.2% |
| 2021 Q1 | -2.97 Million USD | -197571.32% |
| 2020 Q1 | -1359.00 USD | 0.0% |
| 2020 FY | - USD | -9.59% |
| 2020 Q4 | -1503.00 USD | 37.17% |
| 2020 Q3 | -2392.00 USD | 99.76% |
| 2020 Q2 | -1.01 Million USD | -74587.27% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| America Great Health | -447.29 Thousand USD | -8454.144% |
| Ampio Pharmaceuticals, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -29.675% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 66.453% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -142.764% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 0.008% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -113.914% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -13.426% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -14.65% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 64.021% |
| Evolutionary Genomics, Inc. | -913.47 Thousand USD | -4088.63% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -17.794% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 18.054% |
| Innovation1 Biotech Inc. | -5.68 Million USD | -573.183% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -134.719% |
| Molecular Templates, Inc. | 1.43 Million USD | 2775.664% |
| Navidea Biopharmaceuticals, Inc. | -13.87 Million USD | -175.76% |
| NexImmune, Inc. | -28.16 Million USD | -35.837% |
| Orgenesis Inc. | -60.71 Million USD | 36.984% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 25.406% |
| Point of Care Nano-Technology, Inc. | -73.41 Thousand USD | -52016.705% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -136.986% |
| Scopus BioPharma Inc. | -11.71 Million USD | -226.659% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 92.913% |
| Statera Biopharma, Inc. | 38.93 Million USD | 198.272% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -455.811% |
| Trevena, Inc. | -35.28 Million USD | -8.428% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -68162.832% |
| Vaccinex, Inc. | -19.74 Million USD | -93.751% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | -3554.518% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 18.352% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -426.806% |